help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Awai, M.
Right arrow Articles by Seno, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Awai, M.
Right arrow Articles by Seno, S.

American Journal of Pathology, Vol 95, 663-673, Copyright © 1979 by American Society for Investigative Pathology


REGULAR ARTICLES

Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis

M Awai, M Narasaki, Y Yamanoi and S Seno

Rats and rabbits parenterally treated with a large daily dose of ferric nitrilotriacetate manifested diabetic symptoms such as hypergycemia, glycosuria, ketonemia, and ketonuria after approximately 60 days fo treatment. The blood insulin response to oral glucose loading was poor. Heavy iron deposits were found in liver parenchymal cells and in pancreatic exocrine cells, although some iron was deposited in the macrophages and reticuloendothelial cells of the organs. Faint iron staining was found in some pancreatic islet cells, with a reduction in beta granules and weak zinc staining. Cirrhotic liver changes and skin pigment deposition were not observed. Repeated blood withdrawals from ferric-nitrilotriacetate-treated animals resulted in disappearance of hypergycmia, glycosuria, ketonemia, and ketonuria; disappearance of iron from the liver and pancreas; and restoration of islet beta granules to the control level.


This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
V Eybl, D Kotyzova, P Cerna, and J Koutensky
Effect of melatonin, curcumin, quercetin, and resveratrol on acute ferric nitrilotriacetate (Fe-NTA)-induced renal oxidative damage in rats
Human and Experimental Toxicology, April 1, 2008; 27(4): 347 - 353.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
A Mizote, Y Okazaki, M Iqbal, and S Okada
Antioxidant biofactor, a processed grain food, inhibits iron nitrilotriacetate-induced renal tumorigenesis, hyperproliferative response, and oxidative damage
Human and Experimental Toxicology, March 1, 2008; 27(3): 207 - 214.
[Abstract] [PDF]


Home page
Evid Based Complement Alternat MedHome page
T. Jahangir and S. Sultana
Perillyl Alcohol Protects Against Fe-NTA-Induced Nephrotoxicity and Early Tumor Promotional Events in Rat Experimental Model
Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 439 - 445.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
L. Prasad, T. H. Khan, T. Jahangir, and S. Sultana
Effect of gallic acid on renal biochemical alterations in male Wistar rats induced by ferric nitriloacetic acid
Human and Experimental Toxicology, September 1, 2006; 25(9): 523 - 529.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
T. Jahangir, T. H. Khan, L. Prasad, and S. Sultana
Farnesol prevents Fe-NTA-mediated renal oxidative stress and early tumour promotion markers in rats
Human and Experimental Toxicology, May 1, 2006; 25(5): 235 - 242.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
K. Chopra, D. Singh, and V. Chander
Nephrotoxicity and its prevention by catechin in ferric nitrilotriacetate promoted oxidative stress in rats
Human and Experimental Toxicology, March 1, 2004; 23(3): 137 - 143.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
Y. Kawai, A. Furuhata, S. Toyokuni, Y. Aratani, and K. Uchida
Formation of Acrolein-derived 2'-Deoxyadenosine Adduct in an Iron-induced Carcinogenesis Model
J. Biol. Chem., December 12, 2003; 278(50): 50346 - 50354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hashimoto, T. Sibata, H. Wasada, S. Toyokuni, and K. Uchida
Structural Basis of Protein-bound Endogenous Aldehydes. CHEMICAL AND IMMUNOCHEMICAL CHARACTERIZATIONS OF CONFIGURATIONAL ISOMERS OF A 4-HYDROXY-2-NONENAL-HISTIDINE ADDUCT
J. Biol. Chem., February 7, 2003; 278(7): 5044 - 5051.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Nomoto, R. Yamaguchi, M. Kawamura, K. Kohno, and H. Kasai
Analysis of 8-hydroxyguanine in rat kidney genomic DNA after administration of a renal carcinogen, ferric nitrilotriacetate
Carcinogenesis, May 1, 1999; 20(5): 837 - 841.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Ansar, M. Iqbal, and M. Athar
Nordihydroguairetic acid is a potent inhibitor of ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and renal tumour promotion, in mice
Carcinogenesis, April 1, 1999; 20(4): 599 - 606.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Sakurai and A. I. Cederbaum
Oxidative Stress and Cytotoxicity Induced by Ferric-Nitrilotriacetate in HepG2 Cells That Express Cytochrome P450 2E1
Mol. Pharmacol., December 1, 1998; 54(6): 1024 - 1035.
[Abstract] [Full Text]


Home page
Hum Exp ToxicolHome page
M. Iqbal, H. Rezazadeh, S. Ansar, and M. Athar
{alpha}-Tocopherol (vitamin-E) ameliorates ferric nitrilotriacetate (Fe-NTA)-dependent renal proliferative response and toxicity: diminution of oxidative stress
Human and Experimental Toxicology, March 1, 1998; 17(3): 163 - 171.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
K. Ichihashi, T. Osawa, S. Toyokuni, and K. Uchida
Endogenous Formation of Protein Adducts with Carcinogenic Aldehydes. IMPLICATIONS FOR OXIDATIVE STRESS
J. Biol. Chem., June 22, 2001; 276(26): 23903 - 23913.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by the American Society for Investigative Pathology.